Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00686) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Silibinin B
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 2 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=1548994"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytochrome P450 2C8 (CYP2C8) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes. Chem Biol Interact. 2017 Jun 1;271:24-29. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.